CLINICAL_TRIALS
trial_result
· 2021-03-26
Clinical Trial Update: Phase 0 Analysis of Ixazomib (MLN9708) in Patients With Glioblastoma [EARLY_Phase 1]
Summary
Phase 0 analysis of ixazomib (MLN9708) in patients with glioblastoma; early-phase study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Glioblastoma | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2021-03-26